Atomoxetine
NDC 64980-374, Atomoxetine, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-374
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-374 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOMOXETINE HYDROCHLORIDE18 mg/1
Pharmacologic classes
Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-374-03 | 64980037403 | 30 CAPSULE in 1 BOTTLE (64980-374-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1cceab35-dc4a-40bc-a245-10b64820e217NADAC price for package 64980037403
GET /v1/drugs/nadac/64980037403
Use it
Look up 64980-374 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-374 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-374. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.